Back 16 replacement batches released in May 2023

EDQM Strasbourg, France 01/06/2023
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
  • Imprimer en PDF
16 replacement batches released in May 2023

See also:

 

The European Directorate for the Quality of Medicines & HealthCare (EDQM) announces the release of:

  • 16 replacement batches for Ph. Eur. reference standards:

Catalogue code

Name

Batch

Unit quantity

Price

Y0001667

Progesterone for impurity H identification CRS

4

25 mg

79 EUR

Y0000321

Clarithromycin for peak identification CRS

5

10 mg

79 EUR

Y0001544

Insulin glargine for peak identification CRS

4

3.2 mg

79 EUR

Y0000680

Mepyramine impurity C CRS

2

15 mg

79 EUR

P4099910

Pyridostigmine impurity A CRS

2

20 mg

79 EUR

Y0001362

Nicergoline for peak identification CRS

3

1 mg

79 EUR

P1609010

trans-Epoxyphytomenadione CRS

5

5 mg

79 EUR

Y0000165

Tribenoside CRS

5

150 mg

79 EUR

Y0001673

Meldonium impurity C CRS

2

25 mg

79 EUR

Y0002242

Aciclovir for impurity C identification CRS

3

0.3 mg

79 EUR

C2174002

Cilazapril impurity A CRS

2

25 mg

79 EUR

Y0001989

Lacosamide impurity F CRS

2

5 mg

79 EUR

Y0000493

Phloroglucinol (anhydrous) CRS

4

220 mg

79 EUR

Y0000727

Dorzolamide impurity A CRS

4

5 mg

79 EUR

Y0001347

Ginsenoside Rb1 CRS

3

30 mg

79 EUR

M1000000

Methotrexate CRS

9

100 mg

79 EUR

 

Information on reference standards removed from catalogue

  • 11th edition

Following the implementation of the 11th edition, the following standards are officially withdrawn (or replaced) from 1 January 2023.

D0120000

Daunorubicinone (replaced by  Daunorubicin for system suitability Y0002351)

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1 July 2023. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1 January 2024) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

Y0000768

Etodolac for peak identification (replaced by Etodolac impurity mixture Y0002335)

Y0000363

Ciprofibrate for system suitability (replaced by  Ciprofibrate for system suitability A Y00002327)

D0431000

Dequalinium chloride for performance test (replaced by Dequalinium for system suitability Y00002333)

D0430000

Dequalinium chloride (replaced by Dequalinium chloride for ID Y00002332)

M1550000

Methylene chloride (replaced by Methylene chloride - reference spectrum Y00002337)

Y0002317

Marbofloxacin impurity mixture (replaced by Marbofloxacin impurity mixture A)

Y0001496

Cefoxitin for peak identification

C2150000

Cholecalciferol for system suitability

 

Information on reference standards with a future removal from catalogue

  • Supplement 11.1

Following the implementation of Supplement 11.1, the following standards are officially withdrawn (or replaced) from 1 April 2023.

Y0001245

Amylmetacresol for peak identification (remplaced by Amylmetacresol for peak identification A Y0002370)

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1 October 2023. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1 April 2024) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

Y0000264

Diclazuril for veterinary use - reference spectrum (remplaced by Diclazuril Y0002342)

Y0000748

Tibolone - reference spectrum (remplaced by Tibolone Y0002348)

D1500000

Diethylstilbestrol

D1600000

Diethylstilbestrol dimethyl ether

D1700000

Diethylstilbestrol monomethyl ether

Y0002061

Everolimus for system suitability (remplaced by Everolimus for system suitability A Y0002354)

H0837000

L-Homocysteine thiolactone hydrochloride - reference spectrum

Y0000228

Demethylflumazenil - reference spectrum

 

  • Supplement 11.2

Following the implementation of Supplement 11.2, the following standards will be officially withdrawn (or replaced) from 1 July 2023.

C0249000

Calcium ascorbate - reference spectrum (remplaced by Calcium ascorbate dihydrate Y0002379)

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1 January 2024. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1 July 2024) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

T1200000

Thiopental

Y0000265

Flunarizine dihydrochloride - reference spectrum (replaced by Flunarizine dihydrocholride CRS F0189900)

 

Information on change of sales units / price

  • The sales unit of H1100000 Human rabies Ig BRP will be changed from 3 to 1 unit and the price will change from 90€ to 79€ from 15/06/2023. The quantity is sufficient to perform the test mentioned in Ph. Eur. monograph 0723. The sales restriction will also be lifted on 15/06/2023.

Information on change of amount per unit

  • Sodium aminosalicylate dihydrate (Y0001669) CRS batch 1.1 contains 20 mg per unit (previously 10 mg)
  • Mepyramine impurity C CRS batch 2 contains 15 mg per unit (previously 10 mg)
  • Progesterone for impurity H identification CRS batch 4 contains 25 mg per unit (previously 20 mg)

 

Information on change of EDQM storage/shipping conditions

Based on new stability information, storage and shipping conditions have been changed on 15 June 2023 for the following reference standard:

  • Cladribine impurity C (Y0000610) CRS batch 1 is stored at +5°C (previously -20°C) and shipped at ambient temperature (previously on ice at -20°C)

Corrigendum:

  • Since 15 April 2023, 1,1'-Ethylidenebistryptophan (E2205500) CRS batch 9 is stored at -20 °C and shipped at ambient temperature (instead of on ice at -20°C as stated in previous Newsletter).

 

Information on International Chemical Reference Substances (ICRS) and International Standards for Antibiotics (ISA)

ICRS

  • None

ISA

  • None

 

Content of the European Pharmacopoeia RS catalogue

The EDQM proposes more than 3 100 Ph. Eur. RS including a wide range of highly characterised chemical reference substances (CRS), herbal reference standards (HRS) and biological reference preparations (BRP), as well as reference spectra for the tests and assays to be carried out in accordance with the official methods prescribed in the Ph. Eur.

The Ph. Eur. RS catalogue is updated on a daily basis and gives access not only to all the Ph. Eur. RS, but also to:

  • batch validity statements (BVSs) for each reference standard;
  • Safety Data Sheets and Safety Data Statements for hazardous biologicals;
  • leaflets (downloadable PDFs).

For your convenience, the Ph. Eur. RS catalogue is published daily and can be downloaded in in PDF format and in XML format.

When stocks of a given reference standard are low, the EDQM reserves the right to limit the quantities sold to each user to ensure that as many users as possible will receive at least some of the quantities available. Restrictions on quantities are applied at the time the purchase order is received.

Following a request from many users, the quantities allowed in case of sales restrictions now appear in the online catalogue as well as in the catalogue in XML format.

The EDQM is also responsible for the establishment, preparation, storage and distribution of WHO International Chemical Reference Standards (ICRS) and International Standards for Antibiotics (ISA).

 

How to place an RS order

If you wish to place an order, you can send your request to the EDQM either:

  • via the WebStore;
  • or by e-mail to [email protected] (in this case, please ensure that your order, on your company letterhead, states both the catalogue code and substance name and is attached to your e-mail).

A video has been prepared to help user ordering through the RS WebStore.

 

The EDQM helps the users to test some draft texts proposed in Pharmeuropa through Qualified Samples

In some cases, ‘qualified samples’ are made available by the EDQM at the time of publication in Pharmeuropa to allow users to check the changes (e.g. to the related substances test) proposed during the public enquiry and best prepare for the implementation of the monograph.

Where a qualified sample is available, it is described in the briefing note of the Pharmeuropa monograph and may be ordered free of charge by raising a request in the EDQM HelpDesk.

After use, users are kindly requested to share their results with the EDQM.

 

To place an order via the EDQM HelpDesk, please click on European Pharmacopoeia and choose the category Question about General Chapters and Monographs. Providing us with your full shipping address and the title of the corresponding Ph. Eur. monograph, while stating ‘Qualified sample’ in the subject of the query, will help us to rapidly process your request.

For further information on how to use the EDQM HelpDesk, please see the HelpDesk User Manual.